EpiVax, Inc. - Informatics and Immunology
  • Our Company
    • Company Overview
    • Corporate Responsibility
    • Mission, Vision & Values
    • Team
    • Careers
    • Contact Us
  • Pipeline
    • Pipeline Overview
    • BioDefense Vaccines
    • Tregitope: Immunomodulation Power Tool
    • Deimmunization Projects
  • Vaccine Services
    • Vaccine Services
    • iVAX: Web-based Vaccine Design
    • PreVAX Analysis
    • EpiCC
  • Immunogenicity Assessment
    • Immunogenicity Assessment Overview
    • ISPRI Web-based Immunogenicity Assessment
    • PreDeFT Analysis
    • JanusMatrix Analysis
    • High Throughput Antibody Immunogenicity Analysis
    • PANDA Screening
    • ISPRI for Host Cell Proteins
    • Deimmunization
    • Trusted Expert Advice (TEA) Consulting Services
  • Lab Services
    • Lab Services Overview
    • HLA Binding Assays
    • In Vitro Immunization Protocol (IVIP)
  • Press Room
    • Press Room
    • Events
      • Webinars
    • Publication & Poster Search
    • Client Testimonials
    • Thinking Out Loud (Blog)
    • Recipes For Success (Podcast)
  • Contact Us
Select Page
Structure-guided Immunogen Design: Modulating B cell and T cell Immunogenicity of First and Second Generation H7N9 Vaccines

Structure-guided Immunogen Design: Modulating B cell and T cell Immunogenicity of First and Second Generation H7N9 Vaccines

by Annie De Groot | Mar 20, 2019

ACVR immune engineering poster 2019_20Mar2019_930am
T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response

T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response

by Annie De Groot | Aug 15, 2018

T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response

T-cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin

by Sarah Moniz | Dec 19, 2017

Considerations for the rapid deployment of vaccines against H7N9 influenza

Considerations for the rapid deployment of vaccines against H7N9 influenza

by epivax3 | Oct 22, 2016

Considerations for the rapid deployment of vaccines against H7N9 influenza. University of Melborne. Expert Rev Vaccines. 2014 Jul 12
Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-09 Conventional Influenza Vaccine

Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-09 Conventional Influenza Vaccine

by epivax3 | Oct 22, 2016

Vaccine. 2009 Sep 25;27(42):5740-7. PMID: 19660593.
« Older Entries
Next Entries »

Recent Posts

  • Platform shoes, Bellbottoms and #CrueltyFreeFDA!
  • EpiVax and Zoetis to Collaborate on Swine T cell Epitope Prediction Tool: CircoMatch™
  • EpiVax, Inc. Subsidiary, EpiVax Therapeutics Signs Exclusive Collaboration Agreement with GreenLight Biosciences to Develop Personalized Cancer Vaccines
  • #VaxGivesBack and 2022 Charitable Giving
  • EpiVax 2.0 and … Matching your Philanthropy!

Categories

  • EpiVax Immunoncology
  • Events
  • Featured
  • News
  • Recipes for Success – Vlog
  • Thinking Out Loud -Blog
  • Uncategorized
  • Webinars

Discover

  • Vaccine Services
  • Immunogenicity Assessment
  • Deimmunization
  • Lab Services
  • Pipeline

About

  • Our Company
  • Press Room
  • Events
  • Publication & Poster Search
  • Thinking Out Loud (Blog)
  • Contact Us

Connect

© 2023 EpiVax, Inc. – Informatics and Immunology, All rights reserved. Privacy Policy • 188 Valley Street, Suite 424, Providence, RI 02909 • ph: 401.272.2123 • fax: 401.272.7562